CDEK
← All organizations

Deciphera Pharmaceuticals LLC

For profitContributed to NMEWebsite ↗

Also known as: Deciphera Pharmaceuticals LLC | Deciphera Pharmaceuticals, LLC | DECIPHERA PHARMACEUTICALS LLC | DECIPHERA PHARMS

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Mar 1, 2009

First marketed drug

May 15, 2020

First NDA

May 15, 2020

Last known activity

Nov 30, 2025

Acquired by Ono Pharmaceuticals on Apr 29, 2024

Timeline

2000s

  1. Jun 1, 2003

    Deciphera Pharmaceuticals LLC— Founded

2020s

  1. May 15, 2020

    ripretinib— NDA Organization

  2. May 15, 2020

    ripretinib— NDA Secondary Org

  3. Apr 29, 2024

    Ono Pharmaceuticals— Acquired By

  4. Feb 14, 2025

    vimseltinib— Marketing Organization

Drugs by trial phase (22 distinct, 23 trials)

Indications

Studied for

Marketed drugs (2)

Recent trials (35)

Details

Founded
Waltham, MA, US Jun 1, 2003
First NDA
May 15, 2020
Last known activity
Nov 30, 2025

Designations held

  • Orphan drug
  • Fast track
  • Priority review
  • Breakthrough therapy